Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C356337-400 400 µl $393 
ACAP2 / Centaurin Beta 2 Antibody - Western blot of lysates from T47D cell line and mouse brain tissue (from left to right), using ACAP2 antibody diluted at 1:1000 at each lane. A goat anti-rabbit IgG H&L (HRP) at 1:10000 dilution was used as the secondary antibody. Lysates at 20 ug per lane.
ACAP2 / Centaurin Beta 2 Antibody - Western blot of lysate from HT-1080 cell line, using ACAP2 antibody diluted at 1:1000. A goat anti-rabbit IgG H&L (HRP) at 1:10000 dilution was used as the secondary antibody. Lysate at 20 ug.
ACAP2 / Centaurin Beta 2 Antibody - Western blot of lysates from T47D cell line and mouse brain tissue (from left to right), using ACAP2 antibody diluted at 1:1000 at each lane. A goat anti-rabbit IgG H&L (HRP) at 1:10000 dilution was used as the secondary antibody. Lysates at 20 ug per lane.
ACAP2 / Centaurin Beta 2 Antibody - Western blot of lysate from HT-1080 cell line, using ACAP2 antibody diluted at 1:1000. A goat anti-rabbit IgG H&L (HRP) at 1:10000 dilution was used as the secondary antibody. Lysate at 20 ug.
1 of 2
2 of 2

Polyclonal Rabbit anti‑Human ACAP2 / Centaurin Beta 2 Antibody (aa489‑522, WB) LS‑C356337

Polyclonal Rabbit anti‑Human ACAP2 / Centaurin Beta 2 Antibody (aa489‑522, WB) LS‑C356337

Antibody:
ACAP2 / Centaurin Beta 2 Rabbit anti-Human Polyclonal (aa489-522) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human, Mouse
Format:
Unconjugated, Unmodified
Price
Catalog Number
$393
LS-C356337-400
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
ACAP2 / Centaurin Beta 2 Rabbit anti-Human Polyclonal (aa489-522) Antibody
Application:
WB, Peptide-ELISA
Reactivity:
Human, Mouse
Format:
Unconjugated, Unmodified

Specifications

Description
Centaurin Beta 2 antibody LS-C356337 is an unconjugated rabbit polyclonal antibody to Centaurin Beta 2 (ACAP2) (aa489-522) from human. It is reactive with human and mouse. Validated for Peptide-ELISA and WB.
Target
Human ACAP2 / Centaurin Beta 2
Synonyms
ACAP2 | Centaurin, beta 2 | CNT-B2 | CENTB2 | KIAA0041 | Centaurin-beta-2
Host
Rabbit
Reactivity
Human, Mouse (tested or 100% immunogen sequence identity)
Predicted
Rat, Rabbit (at least 90% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Protein A purified
Modifications
Unmodified
Epitope
aa489-522
Specificity
This ACAP2 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 489-522 amino acids from the Central region of human ACAP2.
Applications
  • Western blot (1:1000)
  • Peptide Enzyme-Linked Immunosorbent Assay
Presentation
PBS, 0.09% Sodium Azide
Storage
Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About ACAP2 / Centaurin Beta 2
Q15057 D26069 BAA05064.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/19/2024